Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
A set of surgical procedures performed to establish sufficient outflow to the systemic circulation in individuals with univentricular congenital heart malformations, such as HYPOPLASTIC LEFT HEART SYNDROME, and MITRAL VALVE atresia, associated with systemic outflow obstruction. Follow-on surgeries may be performed and consist of a HEMI-FONTAN PROCEDURE as the stage 2 Norwood procedure and a FONTAN PROCEDURE as the stage 3 Norwood procedure.
Entry Term(s)
Norwood Operation
Norwood Procedure
Norwood Procedure, Stage 1
Norwood Procedure, Stage I
Stage 1 Norwood Procedure
Stage I Norwood Procedure
Previous Indexing
Hypoplastic Left Heart Syndrome/surgery (1995-2010)
A set of surgical procedures performed to establish sufficient outflow to the systemic circulation in individuals with univentricular congenital heart malformations, such as HYPOPLASTIC LEFT HEART SYNDROME, and MITRAL VALVE atresia, associated with systemic outflow obstruction. Follow-on surgeries may be performed and consist of a HEMI-FONTAN PROCEDURE as the stage 2 Norwood procedure and a FONTAN PROCEDURE as the stage 3 Norwood procedure.
A complex cardiac surgical procedure done on individuals with univentricular congenital heart malformations to establish sufficient outflow to the systemic circulation. This operation (Norwood procedure stage 1) involves disconnecting the PULMONARY ARTERY from the heart so that the right ventricle can be connected to the AORTA instead, and the creation of an alternative path for the pulmonary blood flow. The new path for arterial blood flow to the lungs is created by a systemic-to-pulmonary arterial shunt such as a MODIFIED BLALOCK-TAUSSIG SHUNT.